Rucaparib

Common brands: Rubraca, Vitamin D, Neurontin, Ondansetron, Gralise

Top reporter: Pharmaand Gmbh

Benzodiazepine [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Provitamin D2 Compound [EPC]Serotonin-3 Receptor Antagonist [EPC]Programmed Death Receptor-1 Blocking Antibody [EPC]
8,760
Total Reports
2,777
Serious Reports
502
Death Reports
30
Reported Reactions
Death Report Ratio: High (5.73%)

Patient Demographics

Male
607
Female
7,797

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Rucaparib.

# Reaction Reports % of Total
1 FATIGUE 2,547
13.4%
2 NAUSEA 2,258
11.9%
3 MALIGNANT NEOPLASM PROGRESSION 1,184
6.2%
4 DECREASED APPETITE 802
4.2%
5 DIARRHOEA 789
4.2%
6 CONSTIPATION 783
4.1%
7 VOMITING 780
4.1%
8 ASTHENIA 679
3.6%
9 ADVERSE EVENT 571
3.0%
10 CARBOHYDRATE ANTIGEN 125 INCREASED 569
3.0%
11 DYSGEUSIA 565
3.0%
12 ANAEMIA 553
2.9%
13 PRODUCT DOSE OMISSION ISSUE 550
2.9%
14 PLATELET COUNT DECREASED 539
2.8%
15 DRUG INEFFECTIVE 519
2.7%
16 HEADACHE 437
2.3%
17 MALAISE 410
2.2%
18 DIZZINESS 407
2.1%
19 DYSPNOEA 397
2.1%
20 ABDOMINAL PAIN 388
2.0%
21 ABDOMINAL PAIN UPPER 367
1.9%
22 PRODUCT DOSE OMISSION 362
1.9%
23 HAEMOGLOBIN DECREASED 359
1.9%
24 DEATH 351
1.8%
25 ABDOMINAL DISCOMFORT 349
1.8%
26 WHITE BLOOD CELL COUNT DECREASED 315
1.7%
27 WEIGHT DECREASED 296
1.6%
28 PAIN 295
1.6%
29 RED BLOOD CELL COUNT DECREASED 288
1.5%
30 OFF LABEL USE 274
1.4%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.